| Title |
An experimental medicine study of the phosphodiesterase-4 inhibitor, roflumilast, on working memory-related brain activity and episodic memory in schizophrenia patients
|
|---|---|
| Published in |
Psychopharmacology, December 2018
|
| DOI | 10.1007/s00213-018-5134-y |
| Pubmed ID | |
| Authors |
James Gilleen, Yakub Farah, Cate Davison, Sarah Kerins, Lorena Valdearenas, Tolga Uz, Gez Lahu, Max Tsai, Frank Ogrinc, Avi Reichenberg, Steve C. Williams, Mitul A. Mehta, Sukhi S. Shergill |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 22% |
| United States | 2 | 22% |
| Australia | 1 | 11% |
| Malaysia | 1 | 11% |
| Unknown | 3 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 67% |
| Practitioners (doctors, other healthcare professionals) | 2 | 22% |
| Scientists | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 79 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 13% |
| Student > Ph. D. Student | 8 | 10% |
| Student > Bachelor | 7 | 9% |
| Unspecified | 7 | 9% |
| Student > Doctoral Student | 4 | 5% |
| Other | 13 | 16% |
| Unknown | 30 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 8 | 10% |
| Neuroscience | 8 | 10% |
| Biochemistry, Genetics and Molecular Biology | 7 | 9% |
| Unspecified | 7 | 9% |
| Nursing and Health Professions | 6 | 8% |
| Other | 10 | 13% |
| Unknown | 33 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2019.
All research outputs
#6,529,908
of 25,708,267 outputs
Outputs from Psychopharmacology
#1,750
of 5,353 outputs
Outputs of similar age
#121,546
of 447,271 outputs
Outputs of similar age from Psychopharmacology
#28
of 63 outputs
Altmetric has tracked 25,708,267 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 5,353 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.1. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 447,271 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 63 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.